Answers are grounded in this paper and cite their sources.
The immunosuppressive effects of Cyclosporin A (CyA) were evaluated by using a reverse hemolytic plaque assay to detect immunoglobulin- (Ig) secreting cells generated in vitro after stimulation with T cell-dependent and T cell-independent B cell activators. Human mononuclear cells, when cultured in the presence of small doses of CyA (1 µg/ml) failed to produce significant Ig in response to pokeweed mitogen (PWM) and other T cell-dependent activators, but did respond with a normal Ig synthesis to Epstein Barr virus (EBV) of the B95-8 strain. Coculture experiments demonstrated that activation of suppressor cells could not account for the lack of Ig synthesis in the presence of PWM. Rather, a functional inactivation of helper or accessory cell activity could explain the selective inhibitory effect of CyA on T cell and monocyte-dependent Ig synthesis in vitro. Furthermore, the addition of CyA to cultures of EBV immune lymphocytes prevented the activation of EBV-specific suppressor T cells. Because these regulatory T cells limit the potentially unregulated activation of EBV-infected B cells, an important mechanism of immune surveillance is impaired in the presence of CyA. Similarly, activation of suppressor T cells in human newborn lymphocyte cultures, normally induced by PWM, did not occur in the presence of CyA. However, CyA had no inhibitory effect on suppressor T cells found in the peripheral blood of patients with acute, EBV-induced infectious mononucleosis, indicating that this drug does not block all types of suppression, particularly by previously activated suppressor T cells. Thus, CyA profoundly inhibits certain helper and suppressor lymphocyte functions in man while leaving B cell responses induced by EBV (B95-8) relatively unaffected.
No takes yet. Share an insight, caveat, or question.
Tosato et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: